These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4053733)

  • 21. Acquired cross resistance to aminoglycosides in gentamicin-sensitive and gentamicin-resistant strains of enterobacteria.
    Al-Asadi MJ; Towner K; Greenwood D
    J Med Microbiol; 1981 May; 14(2):171-83. PubMed ID: 7014903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative susceptibility of Yersinia enterocolitica, Eikenella corrodens, and penicillin-resistant and penicillin-susceptible Streptococcus pneumoniae to beta-lactam and alternative antimicrobial agents.
    Goldstein EJ; Cherubin CE; Corrado ML; Sierra MF
    Rev Infect Dis; 1982; 4 Suppl():S406-10. PubMed ID: 6294791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro studies of tobramycin, an aminoglycoside antibiotic.
    Dienstag J; Neu HC
    Antimicrob Agents Chemother; 1972 Jan; 1(1):41-5. PubMed ID: 4670427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 25. Strategies in aminoglycoside use and impact upon resistance.
    Acar JF; Goldstein FW; Menard R; Bleriot JP
    Am J Med; 1986 Jun; 80(6B):82-7. PubMed ID: 3637052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
    Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergism at clinically attainable concentrations of aminoglycoside and beta-lactam antibiotics.
    Hooton TM; Blair AD; Turck M; Counts GW
    Antimicrob Agents Chemother; 1984 Oct; 26(4):535-8. PubMed ID: 6517544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Latamoxef in combination with aminoglycosides against Pseudomonas aeruginosa: similarity with ticarcillin.
    Sears SD; Tatem BA; Standiford HC
    Chemotherapy; 1985; 31(2):102-11. PubMed ID: 3921317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid Aminoglycoside NP Test for Rapid Detection of Multiple Aminoglycoside Resistance in Enterobacteriaceae.
    Nordmann P; Jayol A; Dobias J; Poirel L
    J Clin Microbiol; 2017 Apr; 55(4):1074-1079. PubMed ID: 28100594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early synergistic interactions between amikacin and six beta-lactam antibiotics against multiply resistant members of the family Enterobacteriaceae.
    Glew RH; Pavuk RA
    Antimicrob Agents Chemother; 1984 Sep; 26(3):378-81. PubMed ID: 6508266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.
    Venditti M; Brandimarte C; Santini C; Valente B; Martino P; Serra P
    Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative in vitro studies on cefotaxime and desacetylcefotaxime.
    Selwyn S; Bakhtiar M
    Drugs Exp Clin Res; 1986; 12(12):953-65. PubMed ID: 3494587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical comparative evaluation of aminoglycosides.
    Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
    Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic synergy: clinical applications and an in vitro study of cefotaxime-aminoglycoside combinations.
    Faris HM; Dreskin RB
    J S C Med Assoc; 1983 May; 79(5):275-7. PubMed ID: 6308348
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of apalcillin alone and in combination with four aminoglycoside antibiotics against Pseudomonas aeruginosa.
    Höffler U
    Chemotherapy; 1986; 32(3):255-9. PubMed ID: 3086049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial resistance among gram-negative bacilli to newer aminoglycosides and beta-lactams.
    Jain S; Sarkar R
    Indian J Pathol Microbiol; 1991 Oct; 34(4):280-7. PubMed ID: 1818033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Estimation of level of aminoglycosides susceptibility of bacterial strains isolated from patients with systemic and general infections].
    Kowalska-Krochmal B; Dolna I; Dobosz A; Wrzyszcz E; Gościniak G
    Med Dosw Mikrobiol; 2008; 60(3):205-14. PubMed ID: 19143174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii.
    Yadav R; Landersdorfer CB; Nation RL; Boyce JD; Bulitta JB
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2286-98. PubMed ID: 25645842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefepime and amikacin synergy against a cefotaxime-susceptible strain of Enterobacter cloacae in vitro and in vivo.
    Mimoz O; Jacolot A; Padoin C; Caillon J; Louchahi K; Tod M; Samii K; Petitjean O
    J Antimicrob Chemother; 1997 Mar; 39(3):363-9. PubMed ID: 9096186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bactericidal activity of five combinations of penicillin G with aminoglycosides against Streptococcus faecium.
    Le Bouguenec C; Buu-Hoï A
    Eur Heart J; 1984 Oct; 5 Suppl C():29-32. PubMed ID: 6569841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.